EyePoint, Inc. EYPT Pre Funded Warrants Shares Included In Net Income Loss Per Share Calculation

Pre Funded Warrants Shares Included In Net Income Loss Per Share Calculation at other companies

CelcuityCELC

6.1M+7.0%

Disc MedicineIRON

$0-100%

Tarsus Pharmaceuticals, Inc.TARS

312.5K0.0%

Corvus PharmaceuticalsCRVS

$1.26M—

JAN

Janus Living JAN

$187.5M—

Protagonist TherapeuticsPTGX

$34.4M—

Other financials

Income statement

See full

Revenue$696.0K-97.2%

Gross profit$9.8M-30.1%

Operating income-$87.2M-78.6%

Net income-$84.8M-87.7%

EPS (diluted)-$0.99-52.3%

Balance sheet

See full

Cash & equivalents$77.7M-8.7%

Total debt$22.3M-7.3%

Total equity$230.5M-22.8%

Total assets$288.2M-20.5%

Cash flow

See full

Operating cash flow-$80.5M-51.6%

CapEx$997.0K+261%

Free cash flow-$81.5M-52.7%

Valuation

See full

Market cap$1.21B+98.4%

Enterprise value$1.15B+111%

P/S158.5×+148×

Profitability

See full

Operating margin-3,700.9%-4,042pp

Net margin-3,566.6%-3,874pp

FCF margin-3,565.9%-3,884pp

Returns & leverage

See full

Return on equity-102.7%+1,157pp

Debt / equity0.1×0.0×

Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept eypt:PreFundedWarrantsSharesIncludedInNetIncomeLossPerShareCalculation.

The official record: EyePoint, Inc. ’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's pre funded warrants shares included in net income loss per share calculation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is EyePoint, Inc. 's pre funded warrants shares included in net income loss per share calculation?: EyePoint, Inc. (EYPT) reported pre funded warrants shares included in net income loss per share calculation of 2.6M in Q4 2025.
What does pre funded warrants shares included in net income loss per share calculation mean?: The number of shares underlying pre-funded warrants that are included in the calculation of basic and diluted earnings per share. This ensures that the potential impact of these instruments on per-share metrics is transparently accounted for in financial reporting.